BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Verastem Announces Pricing of Public Offering of Common Stock

  Verastem announced the pricing of its previously announced underwritten public offering of approximately $25 million of shares of its common stock.

  December 15, 2017

   · 

  3 min read
• 

  Deals

  Siemens Healthineers Scoops Up 80-Employee Fast Track Diagnostics for Undisclosed Sum

  The acquisition increases the menu of the Siemens Healthineers VERSANT kPCR Molecular System1 by over 80 assays and syndromic panels.

  December 15, 2017

   · 

  4 min read
• Business

  Polydex Pharmaceuticals Reports 3rd Quarter Financial Results - Dec. 15, 2017

  Financial results for the third quarter of fiscal 2018, including the three-month and nine-month periods ended October 31, 2017, are shown together with comparative figures from the same periods in the previous fiscal year.

  December 15, 2017

   · 

  3 min read
• Biotech Bay

  Bay Area’s Global Blood Therapeutics Prices a $100M Common Stock Public Offering

  Cantor Fitzgerald & Co. is the sole book-running manager for the offering.

  December 15, 2017

   · 

  5 min read
• Business

  OrthoPediatrics Corp. Appoints Samuel D. Riccitelli to Its Board of Directors

  The appointment of Mr. Riccitelli brings the Company’s Board to 11 members.

  December 15, 2017

   · 

  2 min read
• Business

  Dr. Sally Ann Forsyth Appointed CEO of Stevenage Bioscience Catalyst

  With scientific and financial expertise and as an open innovation practitioner, Forsyth will lead SBC through its next phase of expansion.

  December 15, 2017

   · 

  2 min read
• Pharm Country

  RespireRx Pharmaceuticals Officers and Directors Elect to Forgive $2,356,733 of Past Due Cash Compensation and Receive Non-Qualified Stock Options to Reduce Balance Sheet Debt

  The Amendment increases the shares issuable under the plan by 3,946,799, from 3,038,461 shares to 6,985,260.

  December 15, 2017

   · 

  9 min read
• Business

  Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations

  Mackenzie will be responsible for leadership of Aquinox’s functions of research, including preclinical operations, chemistry, manufacturing, and controls, quality assurance, and clinical operations.

  December 15, 2017

   · 

  6 min read
• Business

  Tikcro Technologies Reports Third Quarter 2017 Results

  Tikcro Technologies today reported its financial results for the third quarter ended September 30, 2017.

  December 15, 2017

   · 

  6 min read
• Business

  Abbott Raising Quarterly Dividend for 46th Straight Year

  The board of directors of Abbott today increased the company’s quarterly common dividend to 28 cents per share from 26.5 cents per share.

  December 15, 2017

   · 

  1 min read